Skip to main content

Advertisement

ADVERTISEMENT

News

Cathy Biga, ACC President
ACC News
04/09/2024

American College of Cardiology News

American College of Cardiology News ...
Cathie Biga, MSN, FACC, has became president of the American College of Cardiology as of April 8, 2024, and made history as the organization’s first non-physician president. She will serve a one-year term representing over 56,000...
Cathie Biga, MSN, FACC, has became president of the American College of Cardiology as of April 8, 2024, and made history as the organization’s first non-physician president. She will serve a one-year term representing over 56,000...
Cathie Biga, MSN, FACC, has...
04/09/2024
Cath Lab Digest
Beta Blockers Post MI
04/09/2024

American College of Cardiology Scientific Sessions News

American College of Cardiology Scient...
“I think that, following this study, many doctors will not find an indication to routinely treat all their patients with beta blockers following a heart attack,” said Troels Yndigegn, MD, interventional cardiologist at Lund University in...
“I think that, following this study, many doctors will not find an indication to routinely treat all their patients with beta blockers following a heart attack,” said Troels Yndigegn, MD, interventional cardiologist at Lund University in...
“I think that, following this...
04/09/2024
Cath Lab Digest
Vulnerable plaque
04/09/2024

American College of Cardiology Scientific Sessions News

American College of Cardiology Scient...
The trial findings suggest that people with high-risk plaques that are likely to rupture could benefit from PCI as a preemptive measure rather than waiting for a heart attack or other severe reduction in blood flow to occur. The PREVENT trial...
The trial findings suggest that people with high-risk plaques that are likely to rupture could benefit from PCI as a preemptive measure rather than waiting for a heart attack or other severe reduction in blood flow to occur. The PREVENT trial...
The trial findings suggest that...
04/09/2024
Cath Lab Digest

Advertisement

Hypertension
04/09/2024

American College of Cardiology Scientific Sessions News

American College of Cardiology Scient...
“We saw a modest but statistically significant difference in the primary endpoint, but there were no significant differences in other measures of blood pressure, including office systolic or diastolic blood pressure,” said David E. Kandzari,...
“We saw a modest but statistically significant difference in the primary endpoint, but there were no significant differences in other measures of blood pressure, including office systolic or diastolic blood pressure,” said David E. Kandzari,...
“We saw a modest but...
04/09/2024
Cath Lab Digest
aortic stenosis
04/09/2024

American College of Cardiology Scientific Sessions News

American College of Cardiology Scient...
“We can now provide strong data that in this low-risk patient population, you could very safely offer TAVR vs. SAVR,” said Moritz Seiffert, MD, professor of cardiology at BG University Hospital Bergmannsheil, Ruhr University Bochum in Bochum,...
“We can now provide strong data that in this low-risk patient population, you could very safely offer TAVR vs. SAVR,” said Moritz Seiffert, MD, professor of cardiology at BG University Hospital Bergmannsheil, Ruhr University Bochum in Bochum,...
“We can now provide strong data...
04/09/2024
Cath Lab Digest
angina
04/09/2024

American College of Cardiology Scientific Sessions News

American College of Cardiology Scient...
The trial focused on patients with angina due to plaque buildup in the coronary arteries that is not adequately controlled with available treatments. The CSR is an hourglass-shaped stent designed to narrow the vein that collects blood from...
The trial focused on patients with angina due to plaque buildup in the coronary arteries that is not adequately controlled with available treatments. The CSR is an hourglass-shaped stent designed to narrow the vein that collects blood from...
The trial focused on patients...
04/09/2024
Cath Lab Digest

Advertisement

refractory angina
04/09/2024

Shockwave Medical News

Shockwave Medical News
REDUCER-I is a post-market, multi-center, observational study designed to collect long-term outcomes on Shockwave Reducer in a large, ‘real-world’ population of 400 patients.
REDUCER-I is a post-market, multi-center, observational study designed to collect long-term outcomes on Shockwave Reducer in a large, ‘real-world’ population of 400 patients.
REDUCER-I is a post-market,...
04/09/2024
Cath Lab Digest
nonvalvular atrial fibrillation
04/09/2024

Johnson & Johnson News

Johnson & Johnson News
A new analysis of data from the PIONEER AF-PCI clinical trial demonstrates that XARELTO® (rivaroxaban) is associated with a reduced risk of clinically significant bleeding (CSB), and net adverse clinical events (NACE; a composite of...
A new analysis of data from the PIONEER AF-PCI clinical trial demonstrates that XARELTO® (rivaroxaban) is associated with a reduced risk of clinically significant bleeding (CSB), and net adverse clinical events (NACE; a composite of...
A new analysis of data from the...
04/09/2024
Cath Lab Digest
aorto-iliac occlusive disease
04/09/2024

Getinge News

Getinge News
Getinge announced Aetna, a leading health insurance benefits company in the United States, issued a Clinical Policy Bulletin (CPB) addressing peripheral vascular stents. Aetna issued a revised CPB stating that the iCast covered stent...
Getinge announced Aetna, a leading health insurance benefits company in the United States, issued a Clinical Policy Bulletin (CPB) addressing peripheral vascular stents. Aetna issued a revised CPB stating that the iCast covered stent...
Getinge announced Aetna, a...
04/09/2024
Cath Lab Digest

Advertisement

Endovascular Imaging
04/08/2024

American College of Cardiology Scientific Sessions News

American College of Cardiology Scient...
“IVUS is more accurate than angiography in measuring vessel dimensions. It facilitates achieving sufficient vessel lumen diameters and aids in evaluating the response of the target lesion to treatment,” said Young-Guk Ko, MD, the study’s lead...
“IVUS is more accurate than angiography in measuring vessel dimensions. It facilitates achieving sufficient vessel lumen diameters and aids in evaluating the response of the target lesion to treatment,” said Young-Guk Ko, MD, the study’s lead...
“IVUS is more accurate than...
04/08/2024
Cath Lab Digest

Advertisement